From July 1st 2010, the Australian Therapeutic Goods Administration (TGA) adopted the PIC/S GMP guide. The PIC/S GMP guide includes Annnex 20 - Quality Risk Management, which is an adoption of ICH Q9. This presentation discusses what the GMP code requires of pharmaceutical and other manufacturers in terms of quality risk management.
The recent scheduling changes to medicinal cannabis, which includes cannabidiol (CBD) and tetrahydrocannabinols (THC), moving it from Schedule 9 (prohibited substance) to Schedule 8 (controlled ... The post Medicinal cannabis licensing and regulations in a (large) nut shell appeared first on PharmOut.